Proinflammatory stimuli engage Brahma related gene 1 and Brahma in endothelial injury

Fei Fang1, Dewei Chen, Liming Yu

  • 1From the State Key Laboratory of Reproductive Medicine, and Atherosclerosis Research Center, Provincial Key Laboratory of Cardiovascular Disease; and Department of Pathophysiology, Nanjing Medical University, Nanjing, China.

Circulation Research
|August 22, 2013
PubMed

Insights

Brahma related gene 1 (Brg1) and Brahma (Brm) promote leukocyte adhesion in inflammation-driven cardiovascular diseases. Eliminating Brg1/Brm in endothelial cells protects against atherosclerosis, suggesting they are therapeutic targets.

Area of Science:

  • Molecular Biology
  • Cardiovascular Science
  • Epigenetics

Background:

  • Endothelial dysfunction, driven by inflammation, is central to cardiovascular diseases.
  • Leukocyte adhesion to vessel walls, mediated by cell adhesion molecules (CAMs), is a key inflammatory event.
  • The epigenetic regulation of CAMs and their role in disease remain unclear.

Purpose of the Study:

  • To investigate the role of Brahma related gene 1 (Brg1) and Brahma (Brm) in CAM transactivation.
  • To determine the relevance of Brg1 and Brm in the pathogenesis of atherosclerosis.

Main Methods:

  • Assessed Brg1 and Brm expression in endothelial cells and rodent arteries under proinflammatory stimuli.
  • Manipulated Brg1 and Brm levels (overexpression and knockdown) to evaluate effects on CAM transactivation and leukocyte adhesion.
  • Investigated the interaction of Brg1/Brm with nuclear factor κB/p65 at CAM promoters.
  • Analyzed epigenetic modifications and the impact of 17β-estradiol.
  • Utilized an atherosclerosis mouse model (Apoe(-/-)) with endothelial-specific Brg1/Brm deletion.

Main Results:

  • Proinflammatory stimuli increased Brg1 and Brm expression.
  • Brg1/Brm promoted CAM transactivation and leukocyte adhesion; their depletion abrogated these effects.
  • Brg1/Brm interacted with NF-κB/p65, facilitating its recruitment to CAM promoters.
  • Silencing Brg1/Brm disrupted NF-κB/p65 binding kinetics and altered epigenetic changes.
  • 17β-estradiol inhibited Brg1/Brm expression and activity.
  • Endothelial-specific deletion of Brg1/Brm conferred atheroprotection in Apoe(-/-) mice.

Conclusions:

  • Brg1 and Brm integrate inflammatory signals to drive CAM transactivation and endothelial dysfunction.
  • Brg1 and Brm represent potential therapeutic targets for treating inflammation-related cardiovascular diseases.
Abstract

Related Concept Videos

Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Inflammation01:38

Inflammation

Overview
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Acute Inflammation I: Inflammatory Response01:26

Acute Inflammation I: Inflammatory Response

Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...